Lynne Fahey McGrath
Director, Alzamend Neuro, Inc.
Companies
- Alzamend Neuro, Inc.Board member Jun 14, 2021 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Alzamend Neuro, Inc. ALZN25 shares2$33 at $1.33Oct 23, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Oct 23, 2025Sold 30 shares at $2.29 of Alzamend Neuro, Inc.2
- Dec 26, 2023Sold 666 shares at $0.88 of Alzamend Neuro, Inc.3
- Mar 22, 2023Bought 10,000 shares at $0.44 of Alzamend Neuro, Inc.4
- Mar 28, 2022Sold 25,000 shares at $1.21 of Alzamend Neuro, Inc.5
- Mar 28, 2022Sold 25,000 shares at $1.21 of Alzamend Neuro, Inc.6
- Mar 15, 2022Exercised options 50,000 shares of Alzamend Neuro, Inc.7
- Oct 15, 2021Exercised options 47,222 shares of Alzamend Neuro, Inc.8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARAlzamend Neuro, Inc., Board member
- 2
- 3SEC EDGARForm 5 filed May 16, 2024
- 4SEC EDGARForm 4 filed Mar 23, 2023
- 5SEC EDGARForm 4 filed Apr 8, 2022
- 6SEC EDGARForm 4 filed Apr 6, 2022
- 7SEC EDGARForm 4 filed Mar 15, 2022
- 8SEC EDGARForm 4 filed Oct 18, 2021